Navigation Links
$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research
Date:5/27/2009

er at Scottsdale Healthcare Shea Medical Center in Scottsdale. Other clinical sites in the study are at Penn in Philadelphia and at John Hopkins University in Baltimore.

The TGen-Penn team will combine translational methods developed at the University of Pennsylvania with individualized-therapies emphasized by TGen to rapidly move laboratory findings to bedside treatments, benefiting pancreatic cancer patients as quickly as possible. They will test the drugs in combination with existing standard chemotherapy, with the hope of improving quality of life while increasing the percentage of patients surviving beyond one year.

Since its inception in 2002, TGen has pioneered cutting-edge research in genomic medicine, enabling physicians to design targeted and individualized therapies for patients suffering from cancer and other debilitating diseases.

About Dr. Daniel Von Hoff

In addition to his positions at TGen and Scottsdale Healthcare, Dr. Von Hoff is Chief Scientific Officer for US Oncology, and Clinical Professor of Medicine at the University of Arizona. His major interest is in the development of new anticancer agents. Dr. Von Hoff's work focuses on the development of molecularly targeted therapies for patients with pancreatic and other advanced cancers. He is serving a six-year term on the National Cancer Advisory Board and has served on the FDA's Oncology Advisory Committee. Dr. Von Hoff is a past president of the American Association for Cancer Research, was on the AACR and the American Society of Clinical Oncology's Board of Directors, and is a fellow of the American College of Physicians.

About Dr. Craig Thompson

In addition to his position at the Abramson Cancer Center, Dr. Thompson is the Associate Vice President for Cancer Services at the University of Pennsylvania Heath System, director of the Abramson Family Cancer Research Institute and the John H. Glick professor of medicine and cance
'/>"/>

Contact: Steve Yozwiak, TGen Senior Science Writer
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
2. More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities
3. Ophthonix Completes Series AA Financing at $25.9 Million
4. Nearly 1 million Californians seek medical care in Mexico annually
5. Whole Foods Market(R) Lends $2.5 Million to Local Growers, Producers and Food Artisans
6. Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform
7. Cole Foundation injects $2.5 million to bolster leukemia research
8. N.J. Hospitals Face $97 Million in Medicare Cuts
9. Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes
10. Sensors for Medicine and Science, Inc. Completes $10 Million Financing
11. Secretary Shinseki Announces $215 Million in Projects for Rural Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... Atlanta, GA (PRWEB) , ... August 01, 2015 , ... ... iPhone app that is free to download on the Apple AppStore. , The ... energy levels, even mood, thus acting as a tool to view personal health and ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the STASH ... STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured ... tried-and-true products that have stood the test of time. These include lighting products, ...
(Date:7/31/2015)... ... 01, 2015 , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa ... year is the Super Bowl. In the two weeks that separate the conference championships and ... The 2016 Super Bowl game will mark the 50th time it has been held and ...
(Date:7/31/2015)... ... 2015 , ... Last week, the Mesothelioma Applied Research Foundation ... accessed by visiting http://www.curemeso.org/store . , “Our new store features a variety ... a product is purchased, the Meso Foundation receives a $5.00 donation,” said Beth ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... important workshop at its new True North Conference Center. The medical community, social ... the Jacksonville community may be more aligned in the effort to better understand ...
Breaking Medicine News(10 mins):Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3
... June 2 Prime Healthcare Services,("Prime Healthcare"), ... Regional Medical Center from Tenet Healthcare Corporation,("Tenet") ... hospital as Encino Hospital,Medical Center. Prime Healthcare ... acquire two additional Tenet hospitals in California ...
... Representing US$204 Billion in Combined Sales Joined Private, ... Personal Care & Health Products, HONG KONG, ... sales of US$204 billion met 45 Greater China ... at Private Sourcing Events,( http://www.PrivateSourcingEvents.com ) for gifts ...
... belief that breast-feeding equally protects all babies against disease, ... that when it comes to respiratory infections, the protective ... in boys. , Following 119 premature babies in ... found that breast-feeding not only offered more protection to ...
... bed-related injuries are not an issue of concern solely ... conducted by investigators at the Center for Injury Research ... Hospital. The study, published in the June issue of ... bunk bed-related injuries are younger than 10 years of ...
... study of health records from 38 American childrens hospitals ... stay and overall cost. The researchers say their findings ... harm to young patients. , Our study offers a ... pediatric-specific adverse events that are potentially preventable, said study ...
... adults and is emerging in the world of pediatrics. A ... D insufficiency, causes rickets in children and can be treated ... as increased sun exposure. , A new study ... the first study to investigate vitamin D insufficiency in pediatric ...
Cached Medicine News:Health News:Prime Healthcare Services to Acquire Three Hospitals from Tenet Healthcare Corporation 2Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 2Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 3Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 4Health News:More girls than boys benefit from breastfeeding, Hopkins Children's research shows 2Health News:More girls than boys benefit from breastfeeding, Hopkins Children's research shows 3Health News:Bunk beds pose dangers to kids and adults 2Health News:Bunk beds pose dangers to kids and adults 3Health News:Large study identifies most costly adverse events in children's hospitals 2Health News:First study to examine vitamin D insufficiency in pediatric patients with low bone density 2
(Date:7/30/2015)... 2015 IRIDEX Corporation (NASDAQ: IRIX ) ... 2015 financial results after the market closes on ... release, the Company will host a conference call with ... on Thursday, August 6, 2015 to ... developments. Interested parties may access the live ...
(Date:7/30/2015)... PARK, N.J. , July 30, 2015  Unichem ... voluntarily recalling one lot of Hydrochlorothiazide tablets 25 mg ... been initiated as a precautionary measure due to the ... of the product. The risk associated ... Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel,s ...
(Date:7/30/2015)... China , July 30, 2015 Tianyin ... a pharmaceutical company that specializes in the patented biopharmaceutical, ... pharmaceutical ingredients (API), provided updates regarding the notice it ... LLC (the "Exchange") indicating that the Company was below ... forth in Sections 134 and 1101 of the NYSE ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... SEATTLE, Oct. 15 Omeros Corporation (Nasdaq: ... and commercializing products focused on inflammation and disorders of ... Demopulos, M.D., chairman and chief executive officer, will present ... on October 22, 2010 at 1:30 p.m. Eastern time ...
... Tolerated in Multiple Sclerosis Patients -- PARIS, October 15, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Medicine Technology:Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 2Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 3Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 4Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 5Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 6Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 7Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 8Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 9Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 10Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 11Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients 12
... Smartepil LS combines its great ... of vascular lesions with the compactness ... reproduces the same vascular protocols developed ... the same time is indicated for ...
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
Developed to meet the infusion needs in NICU, Anesthesia and Critical Care, the AUTO SYRINGE AS50 Infusion Pump delivers precise, controlled infusions....
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
Medicine Products: